Our comparison of GLP-1 pills and injections explains how price varies with the product and purchase route. Here we count which medicines and forms sellers actually list. The count reflects published prices in our roster.
What the corpus looks like
Across 353 priced rows, injected semaglutide accounts for 158 and injected tirzepatide 159. Together that is 90% of everything this site tracks. The remaining rows divide between oral formulations and a small number of other molecules.
Each row represents a published price. A seller publishing four prices contributes four rows to the product mix.
Checking other products
An offer can be absent from the count if the seller publishes no comparable price. Use the head-to-head trial summary to compare evidence on the two most frequently priced injections.
Why the concentration matters to a price
A market where 90% of the rows are two products is a market where differentiation has to come from somewhere other than the molecule. It comes from price, from what is bundled into it, and from what the seller will tell you — which is why this site measures those three things rather than the drug.
It also means the spread between sellers offering the identical product is the number worth looking at, and that spread is wide. The full arithmetic is in what a GLP-1 actually costs, and the fees that sit outside it in the gap between what is shown and what is billed.